The Trump Administration’s aggressive enforcement of the False Claims Act (FCA) is raising risks for businesses involved with government payments. This panel will examine key DOJ priorities, including false certification liability, tariff evasion, customs violations, Buy American Act issues, civil rights fraud, and Medicare fraud. It will also address the evolving FCA scienter standard post-Supervalu and constitutional challenges to the qui tam provisions.